(19)
(11) EP 4 037 541 A1

(12)

(43) Date of publication:
10.08.2022 Bulletin 2022/32

(21) Application number: 20871120.0

(22) Date of filing: 30.09.2020
(51) International Patent Classification (IPC): 
A61B 1/05(2006.01)
A61N 1/36(2006.01)
(52) Cooperative Patent Classification (CPC):
A61N 1/0556; A61N 1/0456; A61N 1/326; A61N 1/36014; A61N 1/36103; A61N 1/36071; A61N 1/0504; A61N 1/0502
(86) International application number:
PCT/US2020/053630
(87) International publication number:
WO 2021/067498 (08.04.2021 Gazette 2021/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 01.10.2019 US 201962909048 P
25.06.2020 US 202063044208 P

(71) Applicant: Epineuron Technologies Inc.
Mississauga ON L4W 5N9 (CA)

(72) Inventors:
  • WILLAND, Michael, Patrick
    Mississauga, Ontario L4W 5N9 (CA)
  • AGUIRRE, Sergio, David
    Mississauga, Ontario L4W 5N9 (CA)
  • CHAN, Katelyn, Jan, Wai
    Mississauga, Ontario L4W 5N9 (CA)

(74) Representative: Zacco Sweden AB 
P.O. Box 5581 Löjtnantsgatan 21
114 85 Stockholm
114 85 Stockholm (SE)

   


(54) SYSTEMS AND METHODS FOR DELIVERING NEUROREGENERATIVE THERAPY AND REDUCING POST-OPERATIVE AND CHRONIC PAIN